Sentences with phrase «of diagnostic technology»
Represented major elevator and escalator manufacturer in eight - week trial against industry competitor alleging civil fraud, theft of trade secrets, and unfair trade practices arising out of appropriation of diagnostic technology.
http://www.rc.com/ Not exact matches
Part of the problem at that time was the lack of diagnostic and synchronization technology available then to build a working reactor.
Private hospitals are typically the best equipped, with state - of - the art technology and doctors that have studied in the world's best medical universities — many of them speak English and are well acquainted with the newest diagnostic and treatment procedures... some of which may not yet be available in the U.S., for example.
The applications that will pour of this just one technology will transform every industry — from autonomous vehicles to automated radiology / oncology diagnostics.
Wurldtech's edge is that the company has developed diagnostic technology that allows it to do thorough security assessments without taking these massive pieces of industrial equipment offline.
About Proteocyte Diagnostics Proteocyte Diagnostics Inc. is a Canadian molecular diagnostics company that develops and commercializes a novel diagnostics technology, Straticyte ™ that offers objective and accurate early diagnosis of precancers and cancers.
The Chiesi fund will consider a wide range of opportunities, from traditional small molecules and biologics, to gene therapies and cell therapies, to diagnostic and disease management technologies.
In 1996, Alexandria founded Alexandria Venture Investments to actively invest at the cutting edge of novel, breakthrough discoveries in biopharmaceuticals, diagnostics, research tools, medical devices, digital health, and technology.
Wymer: The health care sector has not kept up with information technology over the past year, but I think that new types of medicine, often coupled with new diagnostic techniques, have the potential to extend lives.
Vancouver, B.C. - headquartered CVR Medical Corp., a medical diagnostics technology company, has signed an official letter of intent with Guangzhou LangRun Equity Investment Management Co. Ltd., a professional equity investment fund management platform company headquartered in Guangzhou, China.
Ativa Medical Corp. is a privately held, emerging growth medical diagnostic company developing and commercializing novel point - of - care diagnostic technologies.This technology will enable health care professionals to perform critical hematology and blood chemistry tests on - site and get accurate results within about 5 minutes.
One of the world's leading medical technology companies produces and sells an extensive range of medical supplies, laboratory and diagnostic equipment for health care facilities, life science institutes, and clinical laboratories.
It's a decision which stands to impede access to genes for diagnostic and other purposes, while protecting the right of biomedical companies to extract higher returns for life - saving technology.
The result will be building blocks for industry with the development of new technologies including biomaterials (proteins) from insects and other invertebrates, along with sensory and diagnostic platforms with industrial and environmental applications.
Head Case: Founded by concerned parents of competitive kids, Head Case is a sports technology company with the mission to protect athletes from the cumulative risk of undetected concussions.Head Case are the creators behind Head Case, an affordable three - part head health management systemthat that measures and records head impacts in G - force, provides alerts on impacts of concern, offers diagnostic tools to detect signs and symptoms of potential concussions, and recommends the best treatment facilities in an athlete's current location.
Dubious doctors And even if it works perfectly, a diagnostic AI system still might not be a major part of technology used by physicians in a clinic or hospital.
BACKGROUND: The origins of nuclear medicine involve at least a dozen scientists working on different aspects of the technology over a century, culminating in a surge of diagnostic machines in the 1980s and»90s.
Eric Rubin, a microbiologist at Harvard School of Public Health in Boston, Massachusetts, says that although the probe still requires clinical testing, «a diagnostic based on this principle could make a big impact both in drug development and in controlling disease, especially in areas with limited access to technology».
Chad Mirkin, director of the International Institute of Nanotechnology at Northwestern University, and his colleagues are changing the future of diagnostic medicine with two nanoscale technologies.
As the line between laboratory and bedside blurs, the translation of research methodologies into a clinical setting clearly points to a future where those technologies currently driving discovery will also provide robust tools for molecular diagnostics.
A major focus of my research is on developing new technologies, based on hypothesis - driven, targeted mass spectrometry, for relieving this bottleneck to testing potential new blood - based diagnostics for detection of cancer.
The members of the initiative hope to improve early detection of cancer by making an impact in a variety of areas, including doing epidemiologic studies on risk factors, developing new and improved methods of diagnostic imaging, discovering and verifying new biomarkers as indicators of cancer, and developing new technologies to aid early detection.
«It's a platform for a new class of diagnostics, and a very clear and important practical extension of synthetic biology, opening up a whole generation of new technologies for diagnosis,» says Jim Collins of the Wyss Institute for Biologically Inspired Engineering at Harvard University in Boston, Massachusetts.
The new technology may prove useful in medical diagnostic or other devices where tiny streams of fluid could be turned on or off by switching the surface behavior of a material.
In turn, Parsaghian of Peregrine Pharmaceuticals predicts that antibody - based therapeutics — and diagnostics — will continue to be a growth area in cancer research, together with other protein - based biological agents and stem cell technology.
If scientists better understand how the brain moves after an impact and what movement causes the most damage, Kurt said, «we can design better helmets, we can devise technologies that can do onsite diagnostics, for example in football, and potentially make sideline decisions in real time,» all of which could improve outcomes for those who take a nasty hit to the head.
Twelve scientific divisions are investigating confinement of high - temperature hydrogen plasmas in magnetic fields, heating of plasmas, plasma diagnostics, magnetic field technology, data acquisition and processing, plasma theory, materials research, plasma - wall interaction, and systems studies.
«Thus, there is still a need to develop new diagnostic technologies with higher accuracy, deeper penetration, larger scanning regions, and lower cost for the routine tests of cervical cancer,» Xiao said.
Yeda Research and Development Co. Ltd., the technology transfer arm of the Weizmann Institute, has applied for a patent connected to these findings and recently licensed the rights to miCure Therapeutics to develop a drug and diagnostic method.
«Based upon this technology, we now have a greater understanding of transcriptome regulation, with potential to lead to therapeutic targets and better disease diagnostics.»
As early as 1969, these collaborations led to important products - directly, as with the development of diagnostics for drugs of abuse, Abuscreen; or indirectly, through the development of technologies, which later played a key role in the first isolation and characterization of the a-interferons and to Roche's patents for Roferon.
This technology has the potential to reduce image distortions and more accurately differentiate cancerous from non-cancerous soft tissue,» said Adjunct Assistant Professor Tan Cher Heng, LKCMedicine Lead for Anatomy & Radiology and Senior Consultant with the Department of Diagnostic Radiology at Tan Tock Seng Hospital.
«MRI has a wide array of diagnostic applications and shows promise in breast cancer detection and treatment monitoring,» said Richard Conroy, Ph.D., director of NIBIB Division of Applied Science and Technology.
It's smaller plants that are using different technologies that are more agile and can shift from developing one medicine to another, it's the develop - ment of companion diagnostic technologies that will help identify the people that this particular drug will work best for.
«It's smaller plants that are using different technologies that are more agile and can shift from developing one medicine to another, it's the development of companion diagnostic technologies that will help identify the people that this particular drug will work best for,» he says, predicting that personalized medicine will create a «different dynamic in terms of how the industry is funded and how medicines are manufactured in the future.»
Among the tests that can be run through the minilab technology is a diagnostic for Zika that Holmes said can detect additional strains of the mosquito - borne virus from blood drops finger - pricked from patients.
«In the past, science has focused on identifying the pathogen someone is infected with in the blood or other sample,» said lead author Thomas Burke, Ph.D., director of technology advancement and diagnostics at the DCAGPM.
Close collaborations between academia and health care have driven the implementation of frontline technologies and bioinformatics in clinical diagnostics.
A number of organisations have been involved in the research, including BG Research Ltd, the University of Westminster, Public Health England, Flurogenics Ltd, Diagnostic Systems Division and Virology Division of the United States Army Medical Research Institute of Infectious Diseases and Kwame Nkrumah University of Science and Technology in Ghana.
His current research activities include the implementation of next generation sequencing technologies in a diagnostic setting and the use of this technology to better understand cancer etiology and treatment.
Despite decades of neuroscience advancement, new diagnostic technologies, and a focus on studying children with disabilities, many children with special needs like attention deficit hyperactivity disorder (ADHD) and dyslexia are still being left behind at school.
The editorial highlights that nowadays, more than 20 medical specialties include use of point - of - care ultrasound as a core skill, and that mounting evidence suggests that compared with the stethoscope ultrasound technology can reduce complications, assist in emergency procedures and improve diagnostic accuracy.
The winners of the prize are Maged Al - Sherbiny from Egypt, for his research on vaccines and diagnostics against hepatitis C and schistosomiasis; plant scientist Felix Dapare Dakora from Tshwane University of Technology, Pretoria, in South Africa for his work on legumes and soil bacteria; and Rossana Arroyo of the Centre for Research and Advanced Studies of Mexico's National Polytechnic Institute, who studies trichomoniasis, a parasitic disease.
Said Tiffani Lash, Ph.D., director of the NIBIB program in Microfluidic Bioanalytical Systems, «It is exciting to see the continued growth of microfluidic technologies being used as miniaturized diagnostic platforms, particularly in this case for reducing the incidence of preterm labor and delivery.
The advent of MRI technology, which is used to observe details of specific organs or blood vessels, has been an enormous boon to medical diagnostics over the last few decades.
There are alternatives to centrifugation such as microfluidic technology, which has been widely studied for various applications in biological and chemical analysis, point - of - care testing and diagnostics, and clinical analysis.
«The mouse work is promising enough to adapt these technologies for real time analysis of patient materials so that clinical trials can be designed to test this new diagnostic and drug selection approach,» he said.
The convergence of several factors explains the trend: cheaper genetic sequencing technologies, the discovery of new oncogenes (genes that can cause a normal cell to become cancerous), a new generation of computers and bioinformatics that can analyze vast amounts of data, and a multibillion - dollar effort by researchers inside and outside the pharma industry to develop targeted drugs and companion diagnostics for cancer.
By integrating this dual sensing technology with the ready - to - use devices, it offers great promise in the field of healthcare diagnostics owing to its advantages of portability and point - of - care testing.
Moreover, he believes that investment in technologies such as chip - based methods to rapidly test blood or tissue samples for the presence of anthrax or smallpox would speed the development of related diagnostic tools for regular diseases.